These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16633)

  • 21. Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype.
    Berecz R; de la Rubia A; Dorado P; Fernández-Salguero P; Dahl ML; LLerena A
    Eur J Clin Pharmacol; 2003 May; 59(1):45-50. PubMed ID: 12682803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism.
    Axelsson R; Mårtensson E; Alling C
    Eur J Clin Pharmacol; 1982 Oct; 23(4):359-63. PubMed ID: 7173306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S-oxidation of thioridazine to psychoactive metabolites: an oral dose-proportionality study in healthy volunteers.
    Chakraborty BS; Hawes EM; McKay G; Hubbard JW; Korchinski ED; Midha KK; Choc MG; Robinson WT
    Drug Metabol Drug Interact; 1988; 6(3-4):425-37. PubMed ID: 3271648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The assay of plasma concentration of thioridazine and its metabolites as a function of time.
    Gottschalk LA; Dinovo EC; Nandi BR
    Commun Psychopharmacol; 1978; 2(6):475-9. PubMed ID: 747914
    [No Abstract]   [Full Text] [Related]  

  • 25. Artifacts in the analysis of thioridazine and other neuroleptics.
    Eap CB; Koeb L; Baumann P
    J Pharm Biomed Anal; 1993 Jun; 11(6):451-7. PubMed ID: 8104489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels and half lives of thioridazine and some of its metabolites. I. High doses in young acute schizophrenics.
    Vanderheeren FA; Muusze RG
    Eur J Clin Pharmacol; 1977 Jan; 11(2):135-40. PubMed ID: 320014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: a dose proportionality study.
    Chakraborty BS; Midha KK; McKay G; Hawes EM; Hubbard JW; Korchinski ED; Choc MG; Robinson WT
    J Pharm Sci; 1989 Oct; 78(10):796-801. PubMed ID: 2600782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients.
    Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC
    J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thioridazine 5-sulfoxide diastereoisomers in serum and urine from rats and man after chronic thioridazine administration.
    Hale PW; Poklis A
    J Anal Toxicol; 1985; 9(5):197-201. PubMed ID: 4057956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses.
    Salih IS; Thanacoody RH; McKay GA; Thomas SH
    Clin Pharmacol Ther; 2007 Nov; 82(5):548-54. PubMed ID: 17410120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assay procedures for thioridazine, trifluoperazine, and their sulfoxides and determination of urinary excretion of these compounds in mental patients.
    West NR; Rosenblum MP; Sprince H; Gold S; Boehme DH; Vogel WH
    J Pharm Sci; 1974 Mar; 63(3):417-20. PubMed ID: 4820374
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on thioridazine and mesoridazine metabolism. II. In vivo metabolism of tritiated drugs in rhesus monkeys.
    Forrest IS; Green DE; Blum A; Serra MT; Loeffler KO
    Commun Psychopharmacol; 1979; 3(5):323-7. PubMed ID: 121276
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis and properties of haptens for the development of radioimmunoassays for thioridazine, mesoridazine, and sulforidazine.
    Chakraborty BS; Sardessai MS; Jaworski TJ; Midha KK; Hawes EM
    Pharm Res; 1987 Jun; 4(3):207-13. PubMed ID: 3509283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous determination of thioridazine and its S-oxidized and N-demethylated metabolites using high-performance liquid-chromatography on radially compressed silica.
    Kilts CD; Patrick KS; Breese GR; Mailman RB
    J Chromatogr; 1982 Sep; 231(2):377-91. PubMed ID: 6290516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of liquid-liquid systems for the chromatographic separation of the psychotropic thioridazine and it's metabolites.
    Muusze RG; Huber JF
    J Chromatogr; 1973 Aug; 83():405-20. PubMed ID: 4147446
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations.
    Greendyke RM; Kanter DR
    J Clin Psychopharmacol; 1987 Jun; 7(3):178-82. PubMed ID: 3597804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum levels of thioridazine in psychiatric patients and healthy volunteers.
    Mårtensson E; Roos BE
    Eur J Clin Pharmacol; 1973 Oct; 6(3):181-6. PubMed ID: 4762056
    [No Abstract]   [Full Text] [Related]  

  • 40. Gas chromatographic identification of thioridazine in plasma, and a method for routine assay of the drug.
    Curry SH; Mould GP
    J Pharm Pharmacol; 1969 Oct; 21(10):674-7. PubMed ID: 4390609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.